Loading...
Regulatory Uncertainty And 340B Pressures Will Erode Oncology Margins
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
17.7%7D
-6.7%1Y
17.7%7D
-6.7%You can edit this narrative until May 18 10:09 PM. Then, changes will post as Updates.
You can edit this narrative until May 18 10:09 PM. Then, changes will post as Updates.